Overview
DIA and the Duke-NUS Centre of Regulatory Excellence (CoRE) will host a 2-day conference in Singapore on accelerating access to health products to improve the response to pandemic diseases. Over these 2 days, we will discuss the global impact of infectious diseases and approaches to expedite research and product development (including vaccines and medical devices). We will also explore the pathways to accelerate patient access to innovative products and how to effectively manage a pandemic situation in Asia. Speakers will include experts from Health Authorities, NGOs, as well as the industry and academia.
Download the Exhibitor/Sponsorship Prospectus
Just in!
Dorothee Grimald, PharmD, Director of Global Regulatory Policy for MSD International in Singapore, and Chair for this conference, discusses ways to expedite patient access to combatic therapies in a late-breaking interview. Listen now!
Featured
Want to learn more about Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases? You've come to the right site!
Program Committee
-
Dorothee Grimald, PharmD Director, Global Regulatory Policy
Merck Sharp & Dohme (MSD), Germany -
James Leong, PhD, MPharm Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)
Duke NUS Medical School, Singapore -
Esther Siu-Suet Chu, MBA Head/ Executive Director, Drug Development Operations (APAC)
Allergan Singapore Pte Ltd, Singapore -
Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
Roche, Singapore -
Michelle Cheng, RPh, RAC Head of Regulatory Affairs, Singapore & Asian Emerging Markets
Novartis Singapore Pte Ltd, Singapore -
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore -
Silke Vogel, PhD Deputy Director, Center of Regulatory Excellence (CoRE); Associate Dean
Duke NUS , Singapore -
Shun Jin, MBA Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore -
Jing Ping Yeo, PhD Head - Transformation
George Clinical, Singapore -
Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore -
Stephanie Danandjaja APAC Medical Director
Abbott EPD, Singapore -
Fengyun(Vicky) Han Senior Director, Head of Regulatory Policy for Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore
Have an account?